1. Home
  2. HIHO vs APVO Comparison

HIHO vs APVO Comparison

Compare HIHO & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

N/A

Current Price

$0.80

Market Cap

4.2M

Sector

Industrials

ML Signal

N/A

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

N/A

Current Price

$0.62

Market Cap

4.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HIHO
APVO
Founded
1990
2016
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.3M
IPO Year
2002
2023

Fundamental Metrics

Financial Performance
Metric
HIHO
APVO
Price
$0.80
$0.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $25.50
AVG Volume (30 Days)
21.0K
★ 62.9K
Earning Date
12-14-2026
11-24-2026
Dividend Yield
★ 12.37%
N/A
EPS Growth
N/A
★ 0.13
EPS
★ N/A
N/A
Revenue
N/A
★ $3,114,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.53
52 Week High
$2.21
$10.70

Technical Indicators

Market Signals
Indicator
HIHO
APVO
Relative Strength Index (RSI) 43.30 11.03
Support Level $0.74 N/A
Resistance Level $0.93 $1.98
Average True Range (ATR) 0.05 0.13
MACD 0.00 -0.06
Stochastic Oscillator 30.65 0.01

Price Performance

Historical Comparison
HIHO
APVO

About HIHO Highway Holdings Limited

Highway Holdings Ltd manufactures and sells metal, plastic and electronic parts, components, subassemblies and finished products for OEMs and contract manufacturers. Its products are used in photocopiers, laser printers, print cartridges, electrical connectors, electrical circuits and other applications. The Company also offers tooling design and development, metal stamping, screen printing, plastic injection molding, pad printing and electronic assembly of printed circuit boards. It operates through metal stamping and mechanical OEM manufacturing operations and electronic OEM manufacturing operations, with metal stamping and mechanical OEM manufacturing operations generating maximum revenue. The Company generates maximum revenue from Europe.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: